Bridgeway Capital Management’s InspireMD NSPR Stock Holding History

Bridgeway Capital Management’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,667	Closed	-$34.3K	–	1405
2023 Q2	$34.3K	Hold	13,667	–	–	﹤0.01%	1349
2023 Q1	$15.2K	Sell	13,667 -3,000	-18%	-$3.51K	﹤0.01%	1364
2022 Q4	$14.3K	Hold	16,667	–	–	﹤0.01%	1353
2022 Q3	$25K	Sell	16,667 -20,000	-55%	-$36.5K	﹤0.01%	1385
2022 Q2	$73K	Hold	36,667	–	–	﹤0.01%	1257
2022 Q1	$118K	Hold	36,667	–	–	﹤0.01%	1242
2021 Q4	$111K	Hold	36,667	–	–	﹤0.01%	1208
2021 Q3	$150K	Hold	36,667	–	–	﹤0.01%	1226
2021 Q2	$184K	Buy	36,667 +34,667	+1,733%	+$210K	﹤0.01%	1270
2021 Q1	$20K	Hold	2,000	–	–	﹤0.01%	1351
2020 Q4	$10K	Hold	2,000	–	–	﹤0.01%	1302
2020 Q3	$10K	Hold	2,000	–	–	﹤0.01%	1312
2020 Q2	$14K	Buy	+2,000	New	+$20.3K	﹤0.01%	1290
2014 Q4	–	Hold	0	–	-$506K	–	1490
2014 Q3	–	Hold	0	–	–	–	1062

Other funds holding NSPR

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bridgeway Capital Management's NSPR Position: Q3 2023 in Review

Bridgeway Capital Management sold out of InspireMD (NSPR) in Q3 2023, closing a stake of 13,667 shares — an estimated $34.3K sold.

Bridgeway Capital Management first reported a position in NSPR in Q2 2020 and held it in 13 quarters. The position peaked at $184K in Q2 2021. 26 funds tracked by Wall St. Rank hold NSPR as of Q3 2023.

Bridgeway Capital Management reported no remaining InspireMD position as of Q3 2023 after selling out during the quarter.
Bridgeway Capital Management sold 13,667 InspireMD shares in Q3 2023, an estimated $34.3K.
Bridgeway Capital Management first reported a position in InspireMD in Q2 2020 and held it in 13 quarters.
Bridgeway Capital Management's InspireMD position peaked at $184K in Q2 2021.
26 funds tracked by Wall St. Rank held InspireMD as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.